Could you please provide some details? UBS says they do not have any outstanding issues with Petaquilla and do not contemplate any future problems. What is the magnitude of this "refusal to pay" issue? I spoke with their VP of Private Client Services just a few minutes ago. Likewise a member of management in Zurich denies there are any problems. What is your source? With the internet people can search very quickly, and we cannot find any issue as of yet.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.